Search hospitals > Nevada > Las Vegas
University Medical Center of Southern Nevada
Claim this profileLas Vegas, Nevada 89102
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Uterine Tumors
Conducts research for Lung Cancer
361 reported clinical trials
3 medical researchers
Summary
University Medical Center of Southern Nevada is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Skin Cancer, Breast Cancer, Cancer, Uterine Tumors, Lung Cancer and other specialties. University Medical Center of Southern Nevada is involved with conducting 361 clinical trials across 544 conditions. There are 3 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, and Chowdhury Ahsan, MD.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache6 years of reported clinical research
Expert in Skin Cancer
Expert in Breast Cancer
158 reported clinical trials
235 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation7 years of reported clinical research
Expert in Uterine Tumors
Expert in T-Lymphoblastic Leukemia/Lymphoma
55 reported clinical trials
111 drugs studied
Chowdhury Ahsan, MDUniversity Medical Center of Southern Nevada5 years of reported clinical research
Studies Heart Failure
Studies Coronavirus
4 reported clinical trials
8 drugs studied
Clinical Trials running at University Medical Center of Southern Nevada
Breast Cancer
Bladder Cancer
Lung Cancer
Skin Cancer
Bladder Carcinoma
Stomach Cancer
Kidney Cancer
Acute Lymphoblastic Leukemia
Testicular cancer
Esophageal Adenocarcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Mobile Health
for Breast Cancer
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University Medical Center of Southern Nevada?
University Medical Center of Southern Nevada is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Skin Cancer, Breast Cancer, Cancer, Uterine Tumors, Lung Cancer and other specialties. University Medical Center of Southern Nevada is involved with conducting 361 clinical trials across 544 conditions. There are 3 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, and Chowdhury Ahsan, MD.
Where is University Medical Center of Southern Nevada located?
The University Medical Center of Southern Nevada is situated at 1800 W Charleston Blvd, Las Vegas, NV. For access, from I-15 South, exit at West Charleston Blvd and proceed west; the hospital is located on the right.
Who should I call to ask about financial aid or insurance network?
For financial assistance at University Medical Center of Southern Nevada, contact the Financial Arrangements Office at 806.775.9045 or 1.866.888.3267 for eligibility and application assistance for programs like the Lubbock County Medical Indigent Program. The Resource Assistance Department is also available at 806.775.9014 or 1.800.383.8039 for inpatient financial assistance eligibility. For insurance inquiries, call 702-383-2000.
What insurance does University Medical Center of Southern Nevada accept?
The University Medical Center of Southern Nevada accepts a variety of insurance plans, including most commercial plans for primary and specialty clinics (excluding myGeneration Senior Clinics) and Medicaid plans through Health Plan of Nevada, a UnitedHealthcare Company. Their Medicaid coverage includes comprehensive healthcare services like unlimited primary care visits, mental health appointments, and substance use treatment. Additionally, employees have access to two health plan options: Clark County Self-Funded (PPO) and Exclusive Provider Organization (EPO).
What awards or recognition has University Medical Center of Southern Nevada received?
University Medical Center of Southern Nevada (UMC) is recognized as the region's Metropolitan Anchor Hospital and Nevada's only hospital with a Level 1 trauma center and transplant center. UMC boasts a robust ambulatory division with 15 clinics across the valley and a partnership with the University of Nevada, Las Vegas (UNLV) Medical School, establishing it as a leading academic medical center. Despite financial challenges, UMC reinvests profits into facility improvements, human capital, and community outreach.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.